Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

102 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A2A Receptor Contributes to Tumor Progression in P2X7 Null Mice.
De Marchi E, Pegoraro A, Turiello R, Di Virgilio F, Morello S, Adinolfi E. De Marchi E, et al. Among authors: pegoraro a. Front Cell Dev Biol. 2022 May 18;10:876510. doi: 10.3389/fcell.2022.876510. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35663396 Free PMC article.
Role of the P2X7 receptor in tumor-associated inflammation.
Adinolfi E, De Marchi E, Orioli E, Pegoraro A, Di Virgilio F. Adinolfi E, et al. Among authors: pegoraro a. Curr Opin Pharmacol. 2019 Aug;47:59-64. doi: 10.1016/j.coph.2019.02.012. Epub 2019 Mar 25. Curr Opin Pharmacol. 2019. PMID: 30921559 Review.
P2X7 Receptor in Hematological Malignancies.
De Marchi E, Pegoraro A, Adinolfi E. De Marchi E, et al. Among authors: pegoraro a. Front Cell Dev Biol. 2021 Mar 5;9:645605. doi: 10.3389/fcell.2021.645605. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33763425 Free PMC article. Review.
The P2X7 receptor: A main player in inflammation.
Adinolfi E, Giuliani AL, De Marchi E, Pegoraro A, Orioli E, Di Virgilio F. Adinolfi E, et al. Among authors: pegoraro a. Biochem Pharmacol. 2018 May;151:234-244. doi: 10.1016/j.bcp.2017.12.021. Epub 2017 Dec 27. Biochem Pharmacol. 2018. PMID: 29288626 Review.
ATP Release from Chemotherapy-Treated Dying Leukemia Cells Elicits an Immune Suppressive Effect by Increasing Regulatory T Cells and Tolerogenic Dendritic Cells.
Lecciso M, Ocadlikova D, Sangaletti S, Trabanelli S, De Marchi E, Orioli E, Pegoraro A, Portararo P, Jandus C, Bontadini A, Redavid A, Salvestrini V, Romero P, Colombo MP, Di Virgilio F, Cavo M, Adinolfi E, Curti A. Lecciso M, et al. Among authors: pegoraro a. Front Immunol. 2017 Dec 22;8:1918. doi: 10.3389/fimmu.2017.01918. eCollection 2017. Front Immunol. 2017. PMID: 29312358 Free PMC article.
102 results